VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Amgen Inc. vs Becton, Dickinson and Company
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Becton, Dickinson and Company
BDX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.
View BDX analysisComparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 66 / 100 for Becton, Dickinson and Company).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Becton, Dickinson and Company has 5 segments (29.5% in Medical Essentials).
- Primary market structure: Competitive vs Competitive. Pricing power: Moderate vs Weak.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Becton, Dickinson and Company has 7 across 3.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Becton, Dickinson and Company
Medical Essentials
Single-use medical consumables and specimen collection systems
Global
Healthcare providers and clinical labs
Manufacturer
29.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Amgen Inc. strengths
Becton, Dickinson and Company strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Becton, Dickinson and Company segments
Full profile >Medical Essentials
Competitive
Connected Care
Oligopoly
BioPharma Systems
Oligopoly
Interventional
Competitive
Life Sciences
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.